Integral Diagnostics Limited
ITGDF
$1.00
-$1.06-51.41%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 52.61% | 49.76% | 9.34% | 11.89% | 4.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.61% | 49.76% | 9.34% | 11.89% | 4.52% |
| Cost of Revenue | 54.92% | 52.02% | 11.44% | 14.05% | 4.02% |
| Gross Profit | 47.84% | 45.07% | 4.88% | 7.33% | 5.56% |
| SG&A Expenses | 48.60% | 45.81% | 6.64% | 9.13% | 5.46% |
| Depreciation & Amortization | 33.62% | 31.11% | 2.96% | 5.37% | 7.13% |
| Other Operating Expenses | 58.52% | 55.56% | -1.49% | 0.81% | 120.94% |
| Total Operating Expenses | 51.82% | 48.98% | 9.71% | 12.28% | 4.31% |
| Operating Income | 60.12% | 57.12% | 5.19% | 7.65% | 6.50% |
| Income Before Tax | 26.92% | 24.54% | 100.59% | 100.60% | -29.91% |
| Income Tax Expenses | 128.60% | 124.31% | -21.04% | -19.18% | -21.77% |
| Earnings from Continuing Operations | -16.30% | -17.87% | 99.41% | 99.39% | -32.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.65% | -20.17% | 99.41% | 99.39% | -32.89% |
| EBIT | 60.12% | 57.12% | 5.19% | 7.65% | 6.50% |
| EBITDA | 52.49% | 49.64% | 4.00% | 6.43% | -9.41% |
| EPS Basic | -48.24% | -49.41% | 99.46% | 99.47% | -33.59% |
| Normalized Basic EPS | 24.81% | 22.48% | -94.00% | -94.00% | 706.25% |
| EPS Diluted | -48.24% | -49.41% | 99.46% | 99.47% | -32.00% |
| Normalized Diluted EPS | 22.48% | 20.16% | -94.00% | -94.00% | 760.00% |
| Average Basic Shares Outstanding | 56.47% | 56.47% | 6.11% | 6.11% | 0.36% |
| Average Diluted Shares Outstanding | 59.55% | 59.55% | 6.11% | 6.11% | -0.96% |
| Dividend Per Share | 17.43% | 14.68% | 0.00% | 2.44% | -6.84% |
| Payout Ratio | 1.09% | 1.09% | -167.69% | -167.69% | 0.11% |